Search results
Better Bull Market Buy: Pfizer vs. Moderna
Motley Fool via Yahoo Finance· 5 months agoCOVID-19 has been especially rough for Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) investors over the last couple of years. Shares of both drugmakers...
Better Recovery Story Buy: Pfizer vs Moderna
Motley Fool via Yahoo Finance· 2 months agoA few years ago, both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were flying high: from an earnings and share performance perspective. They each sold...
Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up
Investor's Business Daily· 2 years agoModerna stock broke out Tuesday after the company said adding its personalized cancer vaccine to...
Moderna Stock: Bull vs. Bear
Motley Fool via Yahoo Finance· 3 months agoModerna (NASDAQ: MRNA) shot to stardom in the early days of the pandemic as it brought its coronavirus vaccine from drawing board to commercialization in...
Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
Investor's Business Daily· 1 year agoThe RSV virus has puzzled drugmakers for decades, killing thousands of newborns and older adults in...
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
Investor's Business Daily· 2 years agoThe Food and Drug Administration requested vaccine makers update their Covid shots to include an...
Better Recovery Story Buy: Novavax vs. Teladoc
Motley Fool via Yahoo Finance· 4 months agoEverybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 weeks agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Dow Jones Futures Rise On Bank Of Japan Surprise; Tesla, Moderna Lead Early Movers
Investor's Business Daily· 1 year agoFutures rose and yields fell as the Bank of Japan stayed dovish. The market rally paused while Tesla...
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
InvestorPlace via Yahoo Finance· 3 months agoLast year was a tough one for biotech stocks. The Securities and Exchange Commission reported 41...